Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: Molecular modeling study

被引:53
作者
El-Gamal, Mohammed I. [1 ]
Bayomi, Said M. [1 ]
El-Ashry, Saadia M. [1 ]
Said, Shehta A. [2 ]
Abdel-Aziz, Alaa A. -M. [3 ]
Abdel-Aziz, Naglaa I. [1 ]
机构
[1] Univ Mansoura, Fac Pharm, Dept Med Chem, Mansoura 35516, Egypt
[2] Univ Mansoura, Fac Pharm, Dept Pharmacol, Mansoura 35516, Egypt
[3] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
关键词
Benzylidene acetone oxime ether derivatives; Anti-inflammatory activity; Molecular modeling study; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; STRUCTURE-BASED DESIGN; PROSTAGLANDINS; INDOMETHACIN; DRUGS;
D O I
10.1016/j.ejmech.2009.12.041
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Herein, we report the design, synthesis, and pharmacological properties of a series of substituted benzylidene acetone oxime ether derivatives from the corresponding oxime derivatives. All the newly synthesized compounds were investigated in vivo for their anti-inflammatory activities using carrageenin-induced rat paw oedema model. Among the compounds examined, compounds 5b and 7a showed the highest activity, nearly equivalent to that of the standard drug diclofenac sodium. Hence, they were screened for their analgesic activities using acetic acid-induced writhing model in mice and also, their ulcerogenic effects were studied. Compound 7a was found to possess significant anti-inflammatory and analgesic activities with negligible ulcerogenic effect. Docking study of the synthesized compound 7a into the active site of COX-1 and COX-2 revealed a similar binding mode to SC-558, a selective COX-2 inhibitor. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 36 条
  • [1] ADAMI E, 1964, ARCH INT PHARMACOD T, V147, P113
  • [2] Angadi JS., 2002, INDIAN DRUGS, V39, P515
  • [3] [Anonymous], VOGELS TXB PRACTICAL
  • [4] Structure-based design of COX-2 selectivity into flurbiprofen
    Bayly, CI
    Black, WC
    Léger, S
    Ouimet, N
    Ouellet, M
    Percival, MD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 307 - 312
  • [5] Bhosale SH, 2006, INDIAN J HETEROCY CH, V15, P267
  • [6] From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
    Black, WC
    Bayly, C
    Belley, M
    Chan, CC
    Charleson, S
    Denis, D
    Gauthier, JY
    Gordon, R
    Guay, D
    Kargman, S
    Lau, CK
    Leblanc, Y
    Mancini, J
    Ouellet, M
    Percival, D
    Roy, P
    Skorey, K
    Tagari, P
    Vickers, P
    Wong, E
    Xu, L
    Prasit, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 725 - 730
  • [7] CERVINKA O, 1973, COLLECT CZECH CHEM C, V38, P294
  • [8] Computational methods for the prediction of 'drug-likeness'
    Clark, DE
    Pickett, SD
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (02) : 49 - 58
  • [9] PROSTAGLANDINS AND ASPIRIN
    COLLIER, HOJ
    [J]. NATURE, 1971, 232 (5305) : 17 - &
  • [10] EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON ENDOGENOUS GASTROINTESTINAL PROSTAGLANDINS AND THERAPEUTIC STRATEGIES FOR PREVENTION AND TREATMENT OF NONSTEROIDAL ANTIINFLAMMATORY DRUG-INDUCED DAMAGE
    CRYER, B
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) : 1145 - 1155